Day: April 2, 2019

Combination of first-in-class NBTXR3, radiotherapy, and anti-PD-1 immunotherapy demonstrate efficacy in treating resistant pre-clinical in vivo models of lung cancer

Data presented at AACR Annual Meeting 2019 In vivo study conducted alone or in collaboration with The University of Texas MD Anderson Cancer Center demonstrated: NBTXR3 in combination with a PD-1 inhibitor enhanced an abscopal effect in both sensitive and PD-1-inhibitor-resistant lung cancer models NBTXR3 in combination with a PD-1 inhibitor showed significant reduction of metastatic […]

Chaineum acts as STO Advisor for Carthagea

Chaineum, a France-based corporate finance advisory firm and a pioneering Initial Coin Offering (“ICO”) advisor, accompanies the first French law governed “Security Token Offering” (“STO”) on behalf of its client Carthagea. A STO is a new fundraising trend consisting in the issuance of financial securities to be registered and eventually, in the future, exchanged on […]

Philips presents results from 3-year telehealth program impacting over 100,000 patients across Europe

April 2, 2019 Advancing Care Coordination & Telehealth Deployment at Scale (ACT@Scale) Handbook now available to implement and grow population health management to improve patient care and reduce costs in an aging society Analysis from three-year telehealth deployment in the UK, the Netherlands, Germany, Denmark, and Spain delivers best practice standards for deployment of digital […]